Teva is the latest drugmaker to file suit against Medicare negotiations. But unlike other companies that have challenged the ...
HHS told the Second Circuit that Boehringer Ingelheim’s voluntary participation in Medicare negotiations “undermines” its ...
After seeing its Covid-19 drug fail in a Phase 3 trial last year, Shionogi on Thursday won a $375 million award from HHS to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback